Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety

被引：0

作者：

David A. Calhoun

Nora A. Crikelair

Joseph Yen

Robert D. Glazer

机构：

[1] University of Alabama at Birmingham,Sleep/Wake Disorders Center, Vascular Biology and Hypertension Program

[2] Novartis Pharmaceuticals Corporation,undefined

来源：

Advances in Therapy | 2009年 / 26卷

关键词：

amlodipine; antihypertensive; blood pressure; combination; dual therapy; hydrochlorothiazide; hypertension; triple therapy; valsartan;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1012 / 1023

页数：11

共 76 条

[31]

Poldermans D.(undefined)undefined undefined undefined undefined-undefined

[32]

Glazes R.(undefined)undefined undefined undefined undefined-undefined

[33]

Kargiannis S.(undefined)undefined undefined undefined undefined-undefined

[34]

Pool J.L.(undefined)undefined undefined undefined undefined-undefined

[35]

Glazer R.(undefined)undefined undefined undefined undefined-undefined

[36]

Weinberger M.(undefined)undefined undefined undefined undefined-undefined

[37]

Ruilope L.M.(undefined)undefined undefined undefined undefined-undefined

[38]

Malacco E.(undefined)undefined undefined undefined undefined-undefined

[39]

Khder Y.(undefined)undefined undefined undefined undefined-undefined

[40]

Tuomilehto J.(undefined)undefined undefined undefined undefined-undefined